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Catecholamines are potent in stimulating nerve growth factor (NGF) synthesis in mouse L-M cells. The 
relationship between the structure of catecholamines and their stimulatory effect on NGF synthesis has been 
studied using various 3,4_dihydroxyphenyl derivatives or their analogues. All 3,4_dihydroxyphenyl deriva- 
tives with two saturated carbons on the side chain were potent stimulators, whereas those with only one 
carbon on the side chain were weak stimulators. Drugs lacking the catechol ring were not effective. These 
results suggest hat the catechol part of catecholamines i  essential for the stimulatory effect and that the 
aliphatic side chain potentiates this effect. The present results also suggest he terminal amino residue on 
the side chain is not critical for the effect. 
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1. INTRODUCTION 
Nerve growth factor (NGF) is an essential pro- 
tein for supporting growth and maintenance of 
peripheral sympathetic neurons as well as for 
facilitating the development of some sensory 
neurons during a brief period of early development 
[l]. Data have been recently accumulated that 
show NGF to be synthesized in sympathetically in- 
nervated end organs [2,3]. We have demonstrated 
that fibroblast cells cultured from various mouse 
organs [4,5] and established fibroblastic cell lines 
synthesize and secrete NGF [5,6]. These findings 
Abbreviations: NGF, nerve growth factor; EIA, enzyme 
immunoassay; BSA, bovine serum albumin; CM, condi- 
tioned medium; DOPA, 3,4_dihydroxyphenylalanine; 
DOPS, 3,4_dihydroxyphenylserine; DOPEG, 3,4-di- 
hydroxyphenylglycol; DOPAC, 3,4_dihydroxyphenyl- 
acetic acid; DOMA, 3,4_dihydroxymandelic acid; 
DHBA, 3,4_dihydroxybenzylamine 
suggest that fibroblast cells are responsible for 
NGF synthesis in vivo. We have also demonstrated 
that catecholamines stimulate NGF synthesis in an 
established fibroblast cell line, the mouse L-M cell 
line [6]. 3-Dehydroxy precursors and 3-methoxy 
metabolites of catecholamines do not stimulate 
NGF synthesis, although pyrocatechol has a slight 
effect [6]. These results suggest that the 
stimulatory effect of catecholamines on NGF syn- 
thesis is based on the catechol part of the molecule 
and that the aliphatic side chain potentiates the ef- 
fect. In the present study, we examined in further 
detail the relationship between the structure of 
catecholamines and their ability to stimulate NGF 
synthesis. 
2. MATERIALS AND METHODS 
2.1. Materials 
Mouse submaxillary gland ,&-NGF and anti-& 
NGF antiserum were prepared as reported [7]. 
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Medium 199 was obtained from Flow Labora- 
tories; peptone from Difco; tissue culture vessels 
from Falcon; BSA from Armour; 2,3-dihydroxy- 
pyridine, 3,4_dihydroxybenzaldehyde, DHBA, 
DOPS, 3,4_dihydroxynaphthalene, 3,4-dihydroxy- 
benzoic acid, DOMA, 3,4-dihydroxycinnamic 
acid, DOPEG and DOPAC from Tokyo Kasei; 
pyrocatechol, ( - )-epinephrine, epinine (deox- 
yepinephrine), dopamine, L-DOPA and ( - )- 
isoproterenol from Sigma; ( - )-norepinephrine 
from Nakarai Chemicals. 
Mouse L-M cells were obtained from the 
American Type Culture Collection and maintained 
as monolayer cultures in Medium 199 sup- 
plemented with 0.5% peptone as described before 
[6]. To study the effect of catecholamines or other 
drugs, we inoculated cells into 24-well plates (well 
surface, 2.1 cm2) at a cell density of 2-4 x IO4 
cells/well and cultured them for 3 days in peptone- 
containing medium. Then the medium was 
changed to Medium 199 containing 0.5% BSA 
with or without any drugs, and the cells were 
cultured for 24 h. 
2.3. Two-site EIA 
Two-site EIA for NGF was done as described 
[6,7]. Catecholamines and other drugs used in this 
study, as well as the unconditioned medium, did 
not affect the EIA system. Therefore, the CM was 
used directly in the EIA. 
3. RESULTS 
Catecholamines consist of catechol ring and 
aliphatic side chain. As we had already found that 
pyrocatechol (catechol or o-dihydroxybenzene) is 
slightly effective in stimulating NGF synthesis [6], 
we examined the effect of its analogues (table 1). 
Cells were cultured for 24 h in the presence of the 
drugs at a concentration of 0.1 or 0.2 mM, and 
then the NGF content of the medium of each 
culture was determined. Since NGF synthesized by 
L-M cells is secreted rapidly into the medium, the 
measurement of NGF content in the medium was 
Table 1 
Effects of pyrocatechol and its analogues on the NGF content in the medium of mouse 
L-M cells 
Treatment Structure -Fold increase in 
NGF content 
None (control) 1.00 f 0.07 
Pyrocatechol 0.1 mM 
0.2 mM HO- , 1 no- 0 / 2.01 z!z 0.09 2.31 + 0.38 
OH 
Resorcinol 0.1 mM 0.96 f 0.02 
0.2 mM 1.16 + 0.07 
Hydroquinone 0.1 mM 1.47 + 0.35 
0.2 mM 0 ‘I -OH HO- \ 0.46 f 0.22 
2,3_Dihydroxypyridine 0.1 mM 1.16 f 0.14 
0.2 mM 1.44 It 0.05 
2,3_Dihydroxynaphthalene 0.1 mM 0.85 + 0.12 
0.2 mM 0.69 f 0.08 
Cells were cultured for 24 h with the indicated drugs. The NGF content is expressed 
as -fold increase over that in the absence of a given drug. Data are presented as 
means + SE of four determinations 
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Fig. 1. Effects of catecholamines and their analogues on the NGF content in the medium of mouse L-M cells. Cells were 
incubated for 24 h with various concentrations of (A) epinine (o), epinephrine (0), dopamine (m), DOPA (0); (B) 
isoproterenol (0), norepinephrine (o), DOPS (0). The structures of their side chain are indicated in the figure. The 
NGF content in the medium was determined by EIA and expressed as -fold increase over that in the absence of a given 
drug. Each point is the mean f SE of four determinations. 
considered to reflect the amount of NGF synthe- 
sized [6]. Both resorcinol, which has the phenolic 
dihydroxy group in the me&-position, and hydro- 
quinone, with the group in the para-position, were 
ineffective. Also, neither 2,3_dihydroxynaphtha- 
lene, which is dihydroxylated on the naphthalene 
ring, nor 2,3_dihydroxypyridine, dihydroxylated 
on the pyridine ring instead of the benzene ring, 
was effective. These results indicated that the 
catechol ring is essential for the stimulatory effect 
on NGF synthesis. 
In order to examine the relationship between the 
structure of the aliphatic side chain of 
catecholamines and their stimulatory effect on 
NGF synthesis, we cultured cells for 24 h in the 
presence of various concentrations of epinephrine, 
norepinephrine, dopamine, epinine, isoproterenol, 
or their analogous amino acids (DOPA and 
DOPS). As shown in fig. 1, all drugs tested here in- 
duced an increase in the NGF content of the CM 
in a dose-dependent manner, but to various 
degrees. The structure-effect relationship among 
them may be summarized as follows: (i) ,&- 
Hydroxylation decreased the stimulatory effect on 
NGF synthesis. That is, epinine was more effective 
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than epinephrine, and the effective concentration 
of dopamine was lower than that of 
norepinephrine. (ii) N-substitution enhanced the 
effect, that is, epinine and epinephrine were more 
effective than dopamine and norepinephrine, 
respectively. But the drug with a bulky substituent, 
such as the isopropyl group, reduced the effect. 
Namely, isoproterenol was less effective than 
epinephrine. (iii) cY-Carboxylation resulted in a 
decrease in the effect. DOPA and DOPS were less 
effective than dopamine and norepinephrine, 
respectively. 
Other 3,4_dihydroxyphenyl derivatives were also 
tested for their effects on NGF synthesis. As 
shown in fig.2, DOPEG, which was substituted 
with a hydroxy residue instead of the amino 
residue of norepinephrine, was effective, and its 
effect was almost the same as that of 
norepinephrine (fig. 1). The effect of 3,4-dihy- 
droxyphenylpropionic acid which has a carboxy 
residue instead of the amino residue of dopamine, 
was more effective than dopamine (figs 1 and 2). 
These results indicate that the amino residue of the 
catecholamine is not essential for the stimulatory 
effect. 
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Fig.2. Effects of drugs with catechol part on the NGF content in the medium of mouse L-M cells. The experimental 
conditions were the same as those described in fig-l. (A) 3,4-Dihydroxyphenylpropionic acid (D), 
3,4-dihydroxycinnamic acid (131, DOPAC (e), DOMA (0), 3,4-dihydroxybenzoic acid (0); (B) DOPEG (e), DHBA 
(0), 3,4-dihydroxybenzaldehyde (+), pyrocatechol (0). 
Fig.2 shows that shortening of the chain length 
resulted in a progressive reduction of the 
stimulatory effect on NGF synthesis. The effect of 
the drugs with 1 carbon on the side chain (DHBA, 
DOPAC, and DOMA) was markedly weaker than 
that of the drugs with 2 carbons (dopamine and 
3,4-dihydrox~henylpropionic acid}. The drugs 
without the side chain (3,4-dihydroxybenzoic acid, 
and 3,4_dihydroxybenzaldehyde) were ineffective. 
3,4-Dihydroxycinnamic acid, which has an un- 
satured side chain, was also effective, but it was 
not so potent as 3,4-dihydroxyphenylpropionic 
acid. These results indicate that 3,4-dihydroxy- 
phenyl derivatives with side chains containing two 
saturated carbons are the most potent inducers of 
NGF synthesis. 
4. DISCUSSION 
The present study was aimed at confirming the 
suggestion that the stimulatory effect of 
catecholamines on NGF synthesis is based on the 
catechol part and is potentiated by the side chain. 
In order to confirm the necessity of the catechol 
part, we tested the effect on NGF synthesis of 
pyrocatechol, resorcinol, hydroquinone, 2,3-dihy- 
droxypyridine, and 2,3_dihydroxynaphthalene. In
order to examine the function of the side chain, we 
tested the effect on NGF synthesis of various 
3,4-dihydroxyphenyl derivatives. The results 
presented here have confirmed the necessity of the 
catechol part (table 1) and of a side chain with two 
saturated carbons (figs 1 and 2). The present 
results also indicate that the terminal amino 
residue of catecholamines i  not essential for their 
stimulation of NGF synthesis. 
The mechanism by which catecholamines 
stimulate NGF synthesis is unknown. In a previous 
paper, we showed that this stimuiatory effect is not 
likely to be mediated by LY- or P-adrenergic recep- 
tors [6]. We suggested that norepinephrine and 
epinephrine are taken up into cells [8] and then 
trigger some yet unidentified intracellular reac- 
tion(s) [6], It will be of great interest in the future 
to determine whether there is a correlation between 
the amount of a 3,4-dihydrox~henyl derivative 
transported or permeated into cells and the degree 
of stimulation of NGF synthesis. 
We previously suggested [6] that norepinephrine 
may well stimulate NGF synthesis in end organs in 
vivo as well as in vitro, because the concentration 
of norepinephrine in the vicinity of sympathetic 
nerve terminals was estimated to be sufficiently 
high [9]. Norepinephrine is synthesized in sym- 
pathetic nerves from tyrosine through DOPA and 
dopamine [lo] and then released from nerve ter- 
minals. The possibility that DOPA and/or 
dopamine released from sympathetic nerve ter- 
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minals may be used for the stimulation of NGF 
synthesis is considered to be extremely low. After 
norepinephrine acts as a neurotransmitter on 
receptors of end organs, most of it is taken up 
again into the neurons, while another portion is 
metabolized in end organs and passed into the 
blood. Normetanephrine, DOMA and DOPEG are 
intermediates and 3-methoxy-4-hydroxymandelic 
acid is the major urinary excretion product [l 11. 
The 3,4_dihydroxyphenyl metabolites such as 
DOPEG and/or DOMA might play an important 
role in stimulating NGF synthesis in the end 
organs. In any event, the scheme is very attractive 
that, for their normal growth and maintenance of 
function, peripheral sympathetic neurons depend 
on the NGF synthesized in sympathetically inner- 
vated end organs and that, conversely, this syn- 
thesis is regulated by neuronal activity through the 
neurotransmitter. These results also present the 
possibility that catecholamines or their analogues 
may be used in the future as inducers of NGF syn- 
thesis in vivo. 
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